{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:24:29Z","timestamp":1787095469864,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97229-3","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:22:39Z","timestamp":1780860159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of complications in adulthood following childhood metabolic dysfunction-associated steatohepatitis based on Korean national health insurance data"],"prefix":"10.1038","volume":"16","author":[{"given":"Yunkoo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonjae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"issue":"4","key":"97229_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77 (4), 1335\u20131347 (2023).","journal-title":"Hepatology"},{"issue":"5","key":"97229_CR2","doi-asserted-by":"publisher","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Increasing prevalence of MASLD\/MASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 11 (5), e042843 (2021).","journal-title":"BMJ Open."},{"issue":"14","key":"97229_CR3","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.3346\/jkms.2018.33.e109","volume":"33","author":"Y Kang","year":"2018","unstructured":"Kang, Y., Park, S., Kim, S. & Koh, H. Estimated prevalence of adolescents with nonalcoholic fatty liver disease in Korea. J. Korean Med. Sci. 33 (14), e109 (2018).","journal-title":"J. Korean Med. Sci."},{"key":"97229_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","volume":"207","author":"EL Yu","year":"2019","unstructured":"Yu, E. L. et al. Prevalence of nonalcoholic fatty liver disease in children with obesity. J. Pediatr. 207, 64\u201370 (2019).","journal-title":"J. Pediatr."},{"issue":"10","key":"97229_CR5","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"EL Anderson","year":"2015","unstructured":"Anderson, E. L. et al. The prevalence of Non-Alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS One. 10 (10), e0140908 (2015).","journal-title":"PLoS One"},{"key":"97229_CR6","doi-asserted-by":"crossref","unstructured":"Berardo, C. et al. Nonalcoholic fatty liver disease and Non-Alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. Int. J. Mol. Sci. ;21(24). (2020).","DOI":"10.3390\/ijms21249646"},{"issue":"suppl","key":"97229_CR7","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","volume":"29","author":"SK Han","year":"2023","unstructured":"Han, S. K., Baik, S. K. & Kim, M. Y. Non-alcoholic fatty liver disease: definition and subtypes. Clin. Mol. Hepatol. 29 (suppl), S5\u2013S16 (2023).","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"97229_CR8","first-page":"9","volume":"13","author":"P Paschos","year":"2009","unstructured":"Paschos, P. & Paletas, K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 13 (1), 9\u201319 (2009).","journal-title":"Hippokratia"},{"key":"97229_CR9","doi-asserted-by":"crossref","unstructured":"Temple, J. L., Cordero, P., Li, J., Nguyen, V. & Oben, J. A. A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int. J. Mol. Sci. ;17(6). (2016).","DOI":"10.3390\/ijms17060947"},{"issue":"5","key":"97229_CR10","first-page":"857","volume":"53","author":"I Grattagliano","year":"2007","unstructured":"Grattagliano, I., Portincasa, P., Palmieri, V. O. & Palasciano, G. Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can. Fam Physician. 53 (5), 857\u2013863 (2007).","journal-title":"Can. Fam Physician"},{"key":"97229_CR11","doi-asserted-by":"crossref","unstructured":"Dharmalingam, M. & Yamasandhi, P. G. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J. Endocrinol. Metab. 2018 May-Jun ;22(3):421\u2013428 .","DOI":"10.4103\/ijem.IJEM_585_17"},{"issue":"10","key":"97229_CR12","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184 (10), 2537\u20132564 (2021).","journal-title":"Cell"},{"issue":"1","key":"97229_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","volume":"79","author":"AM Allen","year":"2023","unstructured":"Allen, A. M., Lazarus, J. V. & Younossi, Z. M. Healthcare and socioeconomic costs of MASLD: A global framework to navigate the uncertainties. J. Hepatol. 79 (1), 209\u2013217 (2023).","journal-title":"J. Hepatol."},{"issue":"10","key":"97229_CR14","doi-asserted-by":"publisher","first-page":"R240","DOI":"10.1530\/EC-21-0048","volume":"10","author":"K Kabarra","year":"2021","unstructured":"Kabarra, K., Golabi, P. & Younossi, Z. M. Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocr. Connect. 10 (10), R240\u2013R7 (2021).","journal-title":"Endocr. Connect."},{"issue":"17\u201318","key":"97229_CR15","doi-asserted-by":"publisher","first-page":"E474","DOI":"10.1503\/cmaj.160177","volume":"188","author":"A Andermann","year":"2016","unstructured":"Andermann, A. & Collaboration, C. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ 188 (17\u201318), E474\u2013E83 (2016).","journal-title":"CMAJ"},{"key":"97229_CR16","doi-asserted-by":"crossref","unstructured":"Braveman, P. & Gottlieb, L. The social determinants of health: it\u2019s time to consider the causes of the causes. Public. Health Rep. 2014 Jan-Feb ;129 Suppl 2(Suppl 2):19\u201331 .","DOI":"10.1177\/00333549141291S206"},{"issue":"6","key":"97229_CR17","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/hep.29068","volume":"65","author":"I Doycheva","year":"2017","unstructured":"Doycheva, I., Watt, K. D. & Alkhouri, N. Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic. Hepatology 65 (6), 2100\u20132109 (2017).","journal-title":"Hepatology"},{"issue":"6","key":"97229_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/cld.955","volume":"15","author":"M Sarkar","year":"2020","unstructured":"Sarkar, M. & Suzuki, A. Reproductive health and nonalcoholic fatty liver disease in women: considerations across the reproductive lifespan. Clin. Liver Dis. (Hoboken). 15 (6), 219\u2013222 (2020).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"2","key":"97229_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.sxmr.2019.01.002","volume":"8","author":"DJ Hawksworth","year":"2020","unstructured":"Hawksworth, D. J. & Burnett, A. L. Nonalcoholic fatty liver disease, male sexual dysfunction, and infertility: common links, common problems. Sex. Med. Rev. 8 (2), 274\u2013285 (2020).","journal-title":"Sex. Med. Rev."},{"key":"97229_CR20","doi-asserted-by":"crossref","unstructured":"Fitzpatrick, E. & Dhawan, A. Childhood and adolescent nonalcoholic fatty liver disease: is it different from adults?? J. Clin. Exp. Hepatol. 9 (6), 716\u2013722 (2019 Nov-Dec).","DOI":"10.1016\/j.jceh.2019.05.005"},{"key":"97229_CR21","doi-asserted-by":"crossref","unstructured":"Valentini, F. et al. The origins of NAFLD: the potential implication of intrauterine life and early postnatal period. Cells ;11(3). (2022).","DOI":"10.3390\/cells11030562"},{"issue":"1","key":"97229_CR22","doi-asserted-by":"publisher","first-page":"100964","DOI":"10.1016\/j.jhepr.2023.100964","volume":"6","author":"LS Grinshpan","year":"2024","unstructured":"Grinshpan, L. S. et al. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review. JHEP Rep. 6 (1), 100964 (2024).","journal-title":"JHEP Rep."},{"issue":"2","key":"97229_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3748\/wjg.v29.i2.367","volume":"29","author":"CG Dietrich","year":"2023","unstructured":"Dietrich, C. G., Geier, A. & Merle, U. Non-alcoholic fatty liver disease and COVID-19: harmless companions or disease intensifier? World J. Gastroenterol. 29 (2), 367\u2013377 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"97229_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/hep4.1873","volume":"6","author":"RG Kim","year":"2022","unstructured":"Kim, R. G., Medina, S. P., Magee, C. & Khalili, M. Fatty liver and the coronavirus disease 2019 pandemic: health behaviors, social factors, and telemedicine satisfaction in vulnerable populations. Hepatol. Commun. 6 (5), 1045\u20131055 (2022).","journal-title":"Hepatol. Commun."},{"issue":"7","key":"97229_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/07853890.2016.1219454","volume":"48","author":"G Meng","year":"2016","unstructured":"Meng, G. et al. The overall computer\/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study. Ann. Med. 48 (7), 568\u2013576 (2016).","journal-title":"Ann. Med."},{"key":"97229_CR26","doi-asserted-by":"crossref","unstructured":"Tincopa, M. A., Wong, J., Fetters, M. & Lok, A. S. Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study. BMJ Open. Gastroenterol.  8(1). (2021).","DOI":"10.1136\/bmjgast-2021-000634"},{"key":"97229_CR27","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng, C., Stewart, A. G., Woodman, O. L., Ritchie, R. H. & Qin, C. X. Non-Alcoholic steatohepatitis: A review of its mechanism, models and medical treatments. Front. Pharmacol. 11, 603926 (2020).","journal-title":"Front. Pharmacol."},{"key":"97229_CR28","first-page":"6638306","volume":"2020","author":"CM Muzica","year":"2020","unstructured":"Muzica, C. M. et al. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: A bidirectional relationship. Can. J. Gastroenterol. Hepatol. 2020, 6638306 (2020).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"97229_CR29","doi-asserted-by":"crossref","unstructured":"Rosato, V. et al. NAFLD and Extra-Hepatic comorbidities: current evidence on a multi-organ metabolic syndrome. Int. J. Environ. Res. Public. Health ;16(18). (2019).","DOI":"10.3390\/ijerph16183415"},{"issue":"3","key":"97229_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.pcl.2017.01.008","volume":"64","author":"PKC Selvakumar","year":"2017","unstructured":"Selvakumar, P. K. C., Kabbany, M. N., Nobili, V. & Alkhouri, N. Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications. Pediatr. Clin. North. Am. 64 (3), 659\u2013675 (2017).","journal-title":"Pediatr. Clin. North. Am."},{"key":"97229_CR31","doi-asserted-by":"crossref","unstructured":"Tomeno, W. et al. Complications of non-alcoholic fatty liver disease in extrahepatic organs. Diagnostics (Basel) ;10(11). (2020).","DOI":"10.3390\/diagnostics10110912"},{"issue":"5","key":"97229_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","volume":"75","author":"TG Simon","year":"2021","unstructured":"Simon, T. G. et al. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J. Hepatol. 75 (5), 1034\u20131041 (2021).","journal-title":"J. Hepatol."},{"issue":"2","key":"97229_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","volume":"20","author":"NP Goyal","year":"2016","unstructured":"Goyal, N. P. & Schwimmer, J. B. The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin. Liver Dis. 20 (2), 325\u2013338 (2016).","journal-title":"Clin. Liver Dis."},{"issue":"7","key":"97229_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cgh.2008.03.001","volume":"6","author":"AK HH","year":"2008","unstructured":"HH, A. K., Henderson, J., Vanhoesen, K., Ghishan, F. & Bhattacharyya, A. Nonalcoholic fatty liver disease in children: a single center experience. Clin. Gastroenterol. Hepatol. 6 (7), 799\u2013802 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"97229_CR35","doi-asserted-by":"crossref","unstructured":"Kuntz, E. Hepatology Principles and Practice: History\u00b7 Morphology Biochemistry\u00b7 Diagnostics Clinic\u00b7 (Springer, 2006).","DOI":"10.1007\/3-540-28977-1"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97229-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97229-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97229-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:44:48Z","timestamp":1787093088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97229-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["97229"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97229-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25940"}}